Which prostate cancer patients are suitable for endocrine therapy

Which prostate cancer patients are suitable for endocrine therapy?

How to choose a specific indication has clear indications. Patients who are old, have a short life expectancy, cannot tolerate radical prostate cancer, or have serious dysfunction of major organs such as the heart, lungs, and brain can choose endocrine therapy. Whether it is intravenous or oral medication, the main function is to inhibit androgens in the body to achieve the purpose of treating prostate cancer.

Commonly used endocrine treatment drugs for prostate cancer can be used with endocrine drugs or targeted drugs. They should be used under the guidance of a doctor and not blindly.

The difference between prostatitis and hyperplasia symptoms

The main symptoms of prostatic hyperplasia are frequent urination, urgency, pain when urinating, burning or discomfort in the urethra after urination, and white secretions flowing out of the urethra after urination or defecation, commonly known as white dripping phenomenon. Some patients may experience discomfort in the perineum and lower abdomen, pain in the pubic sacrum and coccyx, and some patients may have impotence and premature ejaculation.

However, prostatitis mostly occurs in young and middle-aged men, while prostatic hyperplasia mainly occurs in middle-aged and elderly men. The two have many similarities in symptoms, and are prone to urinary urgency, frequent urination, painful urination, and endless urination. In severe cases, hematuria may occur. Prostatitis and prostatic hyperplasia are two different diseases.